Not Signed In - AndroScience Corporation Enters Clinical Stage
Wed, 14 Feb 2007 08:00 AM EST
... AndroScience Corporation, a privately held biotech company, has successfully filed an IND for acne indication and will proceed with Human Clinical Trials in the first quarter of 2007. AndroScience has developed its lead compound ASC-J9, a novel anti-androgen that enhances androgen receptor degradation, into a topical cream for acne treatment that will be tested in the clinical trials. [click link for full article] ...
Related Topics
- Clinical Trials
- Pharmacology
- Psychopharmacology
- Ovarian Cancer
- Grief
- Pancreatic Cancer
- End-stage Renal Disease
- Clinical Growth Charts
- Hodgkin's Disease
- Cervical Cancer
- Hypnotherapy
- Epidemiology
- Clinical Laboratory Improvement Amendments
- Depression
- Cirrhosis
- Pension
- Lung Cancer
- Infectious Diseases
- Western/Clinical Treatment and Therapy
- Epidemiology & Prevention of Vaccine-Preventable Diseases
email this page
print this page
bookmark this page
feedback on this page
